Medicenna Therapeutics

Profile

Medicenna is a clinical stage immunotherapy company developing novel and highly differentiated engineered long-acting Superkines and Bifunctional SuperKines for ImmunoTherapies (BiSKITs) for treatment of advanced cancers, autoimmune diseases and inflammatory diseases. Medicenna has a balanced pipeline of late, mid- and early stage (pre-clinical) programs available for partnering, collaborations, co-development, or out-licensing.

medicenna therapeutics

Website

medicenna.com

Contact


Event details

Date: June 22 - 25, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

23 in total